Recursion Pharmaceuticals Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Recursion Pharmaceuticals Inc had 654.47M in cash and cash equivalents.

Recursion Pharmaceuticals Inc reported 343.26M in total liabilities as of the latest reported quarter, including 147.71M in current liabilities and 195.56M in non-current liabilities.

As of the latest reported quarter, Recursion Pharmaceuticals Inc's total assets were 1.47B, consisting of 812.85M in current assets and 661.28M in non-current assets.

Recursion Pharmaceuticals Inc reported 1.13B in total shareholders' equity as of the latest reported quarter.